Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial.

Parsons MW, Yogendrakumar V, Churilov L, Garcia-Esperon C, Campbell BCV, Russell ML, Sharma G, Chen C, Lin L, Chew BL, Ng FC, Deepak A, Choi PMC, Kleinig TJ, Cordato DJ, Wu TY, Fink JN, Ma H, Phan TG, Markus HS, Molina CA, Tsai CH, Lee JT, Jeng JS, Strbian D, Meretoja A, Arenillas JF, Buck BH, Devlin MJ, Brown H, Butcher KS, O'Brien B, Sabet A, Wijeratne T, Bivard A, Grimley RS, Agarwal S, Munshi SK, Donnan GA, Davis SM, Miteff F, Spratt NJ, Levi CR, TASTE investigators

Open source

DOI
10.1016/s1474-4422(24)00206-0
Published
2024 Aug
Container
The Lancet. Neurology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1474-4422-24-00206-0,
  title = {Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial.},
  author = {Parsons MW and Yogendrakumar V and Churilov L and Garcia-Esperon C and Campbell BCV and Russell ML and Sharma G and Chen C and Lin L and Chew BL and Ng FC and Deepak A and Choi PMC and Kleinig TJ and Cordato DJ and Wu TY and Fink JN and Ma H and Phan TG and Markus HS and Molina CA and Tsai CH and Lee JT and Jeng JS and Strbian D and Meretoja A and Arenillas JF and Buck BH and Devlin MJ and Brown H and Butcher KS and O'Brien B and Sabet A and Wijeratne T and Bivard A and Grimley RS and Agarwal S and Munshi SK and Donnan GA and Davis SM and Miteff F and Spratt NJ and Levi CR and TASTE investigators},
  year = {2024},
  journal = {The Lancet. Neurology},
  doi = {10.1016/s1474-4422(24)00206-0},
  url = {https://doi.org/10.1016/s1474-4422(24)00206-0}
}

RIS

TY  - JOUR
TI  - Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial.
AU  - Parsons MW
AU  - Yogendrakumar V
AU  - Churilov L
AU  - Garcia-Esperon C
AU  - Campbell BCV
AU  - Russell ML
AU  - Sharma G
AU  - Chen C
AU  - Lin L
AU  - Chew BL
AU  - Ng FC
AU  - Deepak A
AU  - Choi PMC
AU  - Kleinig TJ
AU  - Cordato DJ
AU  - Wu TY
AU  - Fink JN
AU  - Ma H
AU  - Phan TG
AU  - Markus HS
AU  - Molina CA
AU  - Tsai CH
AU  - Lee JT
AU  - Jeng JS
AU  - Strbian D
AU  - Meretoja A
AU  - Arenillas JF
AU  - Buck BH
AU  - Devlin MJ
AU  - Brown H
AU  - Butcher KS
AU  - O'Brien B
AU  - Sabet A
AU  - Wijeratne T
AU  - Bivard A
AU  - Grimley RS
AU  - Agarwal S
AU  - Munshi SK
AU  - Donnan GA
AU  - Davis SM
AU  - Miteff F
AU  - Spratt NJ
AU  - Levi CR
AU  - TASTE investigators
PY  - 2024
JO  - The Lancet. Neurology
DO  - 10.1016/s1474-4422(24)00206-0
UR  - https://doi.org/10.1016/s1474-4422(24)00206-0
ER  -

APA

MW, P., V, Y., L, C., C, G., BCV, C., ML, R., G, S., C, C., L, L., BL, C., FC, N., A, D., PMC, C., TJ, K., DJ, C., TY, W., JN, F., H, M., TG, P., HS, M., CA, M., CH, T., JT, L., JS, J., D, S., A, M., JF, A., BH, B., MJ, D., H, B., KS, B., B, O., A, S., T, W., A, B., RS, G., S, A., SK, M., GA, D., SM, D., F, M., NJ, S., CR, L., & investigators, T. (2024). Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(24)00206-0

Source records